Lumida
/DSGN
⌘K
Design Therapeutics Inc

Design Therapeutics Inc

DSGN
$12.57USD↓-0.32%-0.04 today

MARKET CAP

785.1M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$12 – $13

52W RANGE

$4
$17

AI Summary

Stalk
Buy NowHigh

In a Stage 2 advancing corrective reset within a broader uptrend, active Lockout Rally dynamics and sustained EMA support justify immediate bullish participation despite overbought readings, focusing on pullbacks into rising EMA confluence near the prior breakout zone.

  • ↑Phase I data: 300 mg DT216 increased frataxin mRNA by 30%
  • ↑$303 M cash supports operations through 2026, minimizing dilution risk
  • ↓Negative profitability metrics undermine return prospects
Full analysis →
Insider Trades0 trades
No trades match the current filters